CD274 and neoplasm: We detected a significantly higher density of PD-L1+ cells (Figure 7B) and significantly higher levels of PD-L1 expression (Figure 7C) in all cells (tumor and nontumor) in post-treatment versus baseline samples from patients with a durable CBR, but not in those from nonresponders.